Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (652)	3/3/1999 9:14:00 PM
From: LLCF	Respond to of 1073

< NBIX > Got into this one today... we're just about cash value here aren't we? I was thinking of a gold stock, but thought this was just a tad more out of favor. :) DAK

To: John Metcalf who wrote (652)	3/4/1999 12:09:00 AM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 1073

<<Do you think NBIX burned a little credibility as a serious CNS researcher?>> No, I don't think so. DHEA isn't thrue neuro-hormon and it is not related to today advance CNS research at NBIX: CRF, melanocortin, neurotransmiter-transporters, neuro-receptors, APL...There lay NBIX future. Also, DHEA come from old age of the all purpose age related wander drug. I do not remember from whom they licensed DHEA A's application. They simply tried and didn't worked. Miljenko